In this video


Pot stocks soar again after DEA reclassifies CBD-based drug

Marijuana stocks ripped higher Thursday after the U.S. Drug Enforcement Administration classified a cannabidiol-based drug made by GW Pharmaceuticals in its least restrictive category, setting the stage for commercial launch.
Thu, Sep 27 20183:39 PM EDT